Recruiting

Xal-Ease with Xalatan

Sponsor:

Augusta University

Code:

NCT00573638

Conditions

Glaucoma

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Xal-Ease device to be used with Xalatan eye drops

Study Details

Brief summary:

The study hypothesis is that the Xal-Ease with increase patient compliance with XALATAN

Conditions

Glaucoma

Study ID

NCT00573638

Start date

Feb, 2005

Status verified date

Aug, 2008

Completion date

Dec, 2009

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • 40 to 80 years old
  • Diagnosis warranting treatment with Xalatan eye drops.
  • ambulatory and well functioning

Exclusion Criteria:

  • non-ambulatory
  • less than 40 or greater than 80 years old
  • Not using Xalatan eye drops

Study Design

Enrollment

50 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Interventions

Xal-Ease device to be used with Xalatan eye drops

This intervention is a drop instillation guide to be used in conjunction with the FDA approved Xalatan eye drop.

Primary outcome measure

  • The primary outcome measure is compliance with the medication XALATAN using and not using the Xal-Ease delivery aid for their glaucoma treatment. [ Time Frame: six months ]

Central Contacts and Locations

Central contacts

Christian D. Nilson, MD

706-721-1150cnilson@mail.mcg.edu

Sandra M. Johnson, MD

706-721-1150sajohnson@mail.mcg.edu

Locations

Medical College of Georgia Health Inc

Recruiting

Augusta, Georgia, United States, 30912

More Information

Sponsor

Augusta University

Last update posted

Aug 8, 2008

Last verified

Aug, 2008

Keywords

  • glaucoma
  • compliance
  • eye drops
  • deliver aid
  • Patients could range anywhere from 40 to 80 years old
  • Patients must have diagnosis requiring treatment with Xalatan.
  • Patients will be male or female and from any racial/ethnic background.

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Augusta University on 2008-08-08.